Figure 1

Assessment of circulating CCR4±, CCR6± CCR10± and CXCR3+ T cells in SLE patients. PBMCs collected from new onset active SLE patients (n = 67) at baseline and HCs (n = 26) were analyzed by flow cytometry for the percentage of different Th cell subsets, including CCR4+, CCR6+, CCR10+ and CXCR3+ T cells. Panel (A) depicted flow cytometry analysis strategy, while panel (B–E) represented quantitative analysis. All dot plots in the data represented mean percentage of Th cells from individual subjects. Differences between groups were analyzed using Mann-Whitney U test. P values < 0.05 represented statistical significance.